An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression. Issue 2 (December 2015) - Rice, Adrian; Latchman, Yvette; Balint, Joseph; Lee, John; Gabitzsch, Elizabeth; Jones, Frank